Stocks · Health care · Biological Products, (No Diagnostic Substances)

Immunovant, Inc.

IMVT Clue Score35

United States Fiscal year ends March CIK 0001764013 Results filed 6 Aug 2026

Add to watchlist

What the insiders did Net selling

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$499.88K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$499.88K

6 of 6 sales

Net

−$499.88K

−$499.88K against sales at will